Production (Stage)
Entera Bio Ltd.
ENTX
$1.86
-$0.23-11.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.57M | -2.36M | -3.02M | -2.15M | -2.02M |
| Total Depreciation and Amortization | 8.00K | 11.00K | 11.00K | 11.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 600.00K | 585.00K | 932.00K | 593.00K | 455.00K |
| Change in Net Operating Assets | 555.00K | 295.00K | -76.00K | 206.00K | -313.00K |
| Cash from Operations | -1.40M | -1.47M | -2.15M | -1.34M | -1.86M |
| Capital Expenditure | -8.00K | -3.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.00K | -3.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.52M | 3.54M | 13.00K | 1.22M | 30.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -186.00K | -323.00K | -- | -- | -- |
| Cash from Financing | 13.34M | 3.22M | 13.00K | 1.22M | 30.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.93M | 1.75M | -2.14M | -119.00K | -1.83M |